Page 370«..1020..369370371372..»

International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing

By admin

Other Tests Show Tissue’s Ability to Focus Light, Pointing to Potential Therapeutic ApplicationsOCEANSIDE, Calif. – May 10, 2010 – International Stem Cell Corporation (OTCBB: ISCO), http://www.internationalstemcell.com/, the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces the results of a second set of experiments confirming that its lab-grown […]

To Read More: International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing
categoriaStem Cell Therapy commentoComments Off on International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing | dataMay 12th, 2010
Read All

Gilead to buy back up to $5 bln in stock – Reuters

By admin

RTT NewsGilead to buy back up to $5 bln in stockReutersLOS ANGELES, May 11 (Reuters) – Biotechnology company Gilead Sciences Inc (GILD.O), whose share price has stagnated this year following …Large buyback program from Gilead Sciences bolsters biotech sharesMarketWatchGilead Sciences board approves $5 billion buybackBusinessWeekGilead Preps $5B Share BuybackEmii.comall 39 news articles »

To Read More: Gilead to buy back up to $5 bln in stock – Reuters
categoriaUncategorized commentoComments Off on Gilead to buy back up to $5 bln in stock – Reuters | dataMay 11th, 2010
Read All

Advanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Honored … – MarketWatch (press release)

By admin

HotStockedAdvanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Honored …MarketWatch (press release)Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. …Advanced Cell Technology, Inc. (OTC:ACTC) Stock Fires Reversal’s WicksHotStockedall 14 news articles »

To Read More: Advanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Honored … – MarketWatch (press release)
categoriaUncategorized commentoComments Off on Advanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Honored … – MarketWatch (press release) | dataMay 11th, 2010
Read All

Baking soda can clean your teeth, clear your complexion

By admin

(NaturalNews) Many components of the modern western diet – meats, fish, dairy products, most grains, sugars, alcohol and caffeinated drinks (in fact, almost everything except vegetables, millet, most fruits and, as we have just seen, apple cider vinegar) – contribute to one’s body becoming too acidic. This in turn can open the door to a […]

To Read More: Baking soda can clean your teeth, clear your complexion
categoriaIntegrative Medicine commentoComments Off on Baking soda can clean your teeth, clear your complexion | dataMay 9th, 2010
Read All

CSC news links 2010-05-08

By admin

For links to recent news items about CSC, visit this [Topsy] page. Examples of two news items that have received attention in the past week:? New research links ovarian hormones with breast stem-cell growth – Globe and Mail http://bit.ly/brT71E. Hashtag: #cancerSC. Posted to Twitter on Wed May 06, 2010 via TweetDeck. [PubMed Citation] Broccoli compound […]

To Read More: CSC news links 2010-05-08
categoriaStem Cell Therapy commentoComments Off on CSC news links 2010-05-08 | dataMay 9th, 2010
Read All

Genzyme OKs $2B buyback, mulls options for 3 units – The Associated Press

By admin

ReutersGenzyme OKs $2B buyback, mulls options for 3 unitsThe Associated PressBiotechnology company Genzyme Corp. said Thursday its board of directors approved a $2 billion stock buyback program and the company said it will explore …Genzyme to buy back $2 billion in stockBoston GlobeIcahn Tries to Replace 4 Directors at GenzymeNew York Times (blog)Special Report: Inside […]

To Read More: Genzyme OKs $2B buyback, mulls options for 3 units – The Associated Press
categoriaUncategorized commentoComments Off on Genzyme OKs $2B buyback, mulls options for 3 units – The Associated Press | dataMay 7th, 2010
Read All

InterMune crashes, drags down biotech index – MarketWatch

By admin

TopNews Singapore (press release)InterMune crashes, drags down biotech indexMarketWatchInterMune’s woes also weighed heavily on the NYSE Arca Biotechnology Index (INDEX:BTK) , of which InterMune is a leading component. …FDA rejects InterMune lung drug, shares fallReutersInterMune’s Surprise Rejection Leads Stock to PlummetBusinessWeekInterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone …PR Newswire (press release)all 189 news […]

To Read More: InterMune crashes, drags down biotech index – MarketWatch
categoriaUncategorized commentoComments Off on InterMune crashes, drags down biotech index – MarketWatch | dataMay 6th, 2010
Read All

International Stem Cell Corporation Signs Financing Agreement

By admin

OCEANSIDE, CA –May 5, 2010 – International Stem Cell Corporation (ISCO.OB), http://www.intlstemcell.com, today announced it has entered into a definitive agreement dated May 4, 2010 (‘the Agreement”) with Socius CG II, Ltd. (“Socius”), pursuant to which Socius has committed to purchase a single tranche of up to $10 million in non-convertible Series F Preferred Stock […]

To Read More: International Stem Cell Corporation Signs Financing Agreement
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation Signs Financing Agreement | dataMay 6th, 2010
Read All

Icahn Tries to Replace 4 Directors at Genzyme – New York Times (blog)

By admin

ReutersIcahn Tries to Replace 4 Directors at GenzymeNew York Times (blog)Genzyme, one of the nation’s oldest and largest biotechnology companies, has been struggling to assuage investors unhappy over manufacturing problems that …Icahn turns up the heat on GenzymeBoston GlobeSpecial Report: Inside the battle for Genzyme’s futureReutersSpecial Report: Inside the Battle for Genzyme’s FutureABC Newsall 19 […]

To Read More: Icahn Tries to Replace 4 Directors at Genzyme – New York Times (blog)
categoriaUncategorized commentoComments Off on Icahn Tries to Replace 4 Directors at Genzyme – New York Times (blog) | dataMay 6th, 2010
Read All

Gore highlights biotechnology’s role in improving environment, addressing … – istockAnalyst.com (press release)

By admin

Earthtimes (press release)Gore highlights biotechnology’s role in improving environment, addressing …istockAnalyst.com (press release)CHICAGO, May 5, 2010 (Xinhua News Agency) — Former US vice president and climate change activist Al Gore said on Wednesday that biotechnology should play a …Al Gore Addresses Biotechnology Convention in ChicagoChicago Public RadioBrazilian Biotechnology Present at BIO 2010 Is Looking for […]

To Read More: Gore highlights biotechnology’s role in improving environment, addressing … – istockAnalyst.com (press release)
categoriaUncategorized commentoComments Off on Gore highlights biotechnology’s role in improving environment, addressing … – istockAnalyst.com (press release) | dataMay 6th, 2010
Read All

Google to Invest in Regenerative Medicine

By admin

While the US government prints money to shore up failing and broken business models which no one likes but are considered simply too big (not too important or significant or even useful) to fail, Google is making money and investing it in start ups who expect nothing less than to create “disruptive, even world-changing technologies”.No […]

To Read More: Google to Invest in Regenerative Medicine
categoriaRegenerative Medicine commentoComments Off on Google to Invest in Regenerative Medicine | dataMay 5th, 2010
Read All

InterMune, Myriad, News Corp., XL Capital: US Equity Preview – BusinessWeek

By admin

RTT NewsInterMune, Myriad, News Corp., XL Capital: US Equity PreviewBusinessWeekMay 5 (Bloomberg) — Shares of the following companies may have unusual moves in US trading. Stock symbols are in parentheses. …US HOT STOCKS: Intermune, Myriad Genetics Drop In Late TradingWall Street JournalMyriad Genetics Reports Financial Results for Fiscal 2010 Third QuarterMarketWatch (press release)Salt Lake’s Myriad […]

To Read More: InterMune, Myriad, News Corp., XL Capital: US Equity Preview – BusinessWeek
categoriaUncategorized commentoComments Off on InterMune, Myriad, News Corp., XL Capital: US Equity Preview – BusinessWeek | dataMay 5th, 2010
Read All

Biotech-center director sees big step ahead – Winston-Salem Journal

By admin

Triad Business JournalBiotech-center director sees big step aheadWinston-Salem JournalNancy Johnston says she believes that the Triad’s biotechnology sector is on the cusp of taking a major step forward in …Johnston to lead biotech centerWinston-Salem JournalBiotech Center picks marketing executive to lead Piedmont Triad officeLocal Tech Wire (blog)all 5 news articles »

To Read More: Biotech-center director sees big step ahead – Winston-Salem Journal
categoriaUncategorized commentoComments Off on Biotech-center director sees big step ahead – Winston-Salem Journal | dataMay 5th, 2010
Read All

2010 BIO International Convention opens in Chicago – Xinhua

By admin

Xinhua2010 BIO International Convention opens in ChicagoXinhuaCHICAGO, May 4 (Xinhua) — 2010 BIO (Biotechnology Industry Organization) International Convention, the world’s largest gathering of the global biotech …BioCurex, Inc. Executive Chairman Denis Burger to Present at the Renowned BIO …MarketWatch (press release)Patrick cancels BIO visit amid water crisisBizjournals.comBiotech industry provides almost 25000 jobs in state, report […]

To Read More: 2010 BIO International Convention opens in Chicago – Xinhua
categoriaUncategorized commentoComments Off on 2010 BIO International Convention opens in Chicago – Xinhua | dataMay 5th, 2010
Read All

Patent Applications Backed Up: So Are New Jobs – Inventorspot

By admin

Patently-OPatent Applications Backed Up: So Are New JobsInventorspotPatents created jobs during the Industrial Revolution and patents need to continue to create jobs in the digital and biotechnology age. …Backlog of patents still stifling potential jobs, director saysMilwaukee Journal SentinelStem Cell Patents Under FireGoozNew (blog)Kappos Talks Patent Reform and Gene Patents at BIO ConventionIPWatchdog.comall 170 news […]

To Read More: Patent Applications Backed Up: So Are New Jobs – Inventorspot
categoriaUncategorized commentoComments Off on Patent Applications Backed Up: So Are New Jobs – Inventorspot | dataMay 5th, 2010
Read All

Governor Martin O’Malley Named BIO Governor of the Year – Citybizlist (press release)

By admin

Crain’s Chicago BusinessGovernor Martin O’Malley Named BIO Governor of the YearCitybizlist (press release)BALTIMORE, MD (May 3, 2010) – Recognized for his outstanding leadership in growing and promoting Maryland’s biotechnology industry, Governor Martin O’Malley …Author : Biotechnology Industry OrganizationEarthtimes (press release)Latest biotech industry report shows Wisconsin gaining jobsWTN NewsWisconsin biotech industry growsThe Business JournalMinneapolis Star Tribune –PR […]

To Read More: Governor Martin O’Malley Named BIO Governor of the Year – Citybizlist (press release)
categoriaUncategorized commentoComments Off on Governor Martin O’Malley Named BIO Governor of the Year – Citybizlist (press release) | dataMay 4th, 2010
Read All

researchers awarded $4 million in grants from state stem cell agency – UC Los Angeles

By admin

Times Onlineresearchers awarded $4 million in grants from state stem cell agencyUC Los Angeles… an associate professor of microbiology, immunology and molecular genetics, who was awarded $1.37 million and whose grant received the highest score; …UCI Basic Research On Stem Cells Funded By CaliforniaMedical News Today (press release)all 74 news articles »

To Read More: researchers awarded $4 million in grants from state stem cell agency – UC Los Angeles
categoriaUncategorized commentoComments Off on researchers awarded $4 million in grants from state stem cell agency – UC Los Angeles | dataMay 3rd, 2010
Read All

Health care reform bill dooms America to Pharma-dominated sickness and suffering

By admin

Today the medical mafia struck another devastating blow to the health and freedom of all Americans. With the support of an inarguably corrupt Congress that has simply abandoned the real needs of the American people, the sick-care industry has locked in a high-profit scheme of disease and monopoly-priced pharmaceuticals in a nation that can ill […]

To Read More: Health care reform bill dooms America to Pharma-dominated sickness and suffering
categoriaIntegrative Medicine commentoComments Off on Health care reform bill dooms America to Pharma-dominated sickness and suffering | dataMay 3rd, 2010
Read All

Court hears arguments today on genetic engineering of crops – SuburbanJournals

By admin

AFPCourt hears arguments today on genetic engineering of cropsSuburbanJournalsWASHINGTON — The US Supreme Court today will hear oral arguments in a case involving Monsanto Co., the high court’s first case dealing with genetically …Court hears arguments today on genetic engineering of cropsTrading Markets (press release)Supreme Court hearing on GMO AlfalfaBiofortified (blog)Both Sides Optimistic After US […]

To Read More: Court hears arguments today on genetic engineering of crops – SuburbanJournals
categoriaUncategorized commentoComments Off on Court hears arguments today on genetic engineering of crops – SuburbanJournals | dataMay 2nd, 2010
Read All

Dendreon leads drug stocks higher – MarketWatch

By admin

ArtujiDendreon leads drug stocks higherMarketWatchThe NYSE Arca Pharmaceutical Index (INDEX:DRG) edged up 0.4% at 299.09 and the NYSE Arca Biotechnology Index (INDEX:BTK) rose 0.7% to 1227.88.Dendreon’s Clean Bill Of HealthForbesMajor turnaround for Dendreon as US FDA approves Provenge for advanced …The Pharma LetterDendreon Shares Pop On Provenge ApprovalDaily MarketsOrange County Business Journal –Puget Sound Business Journal –Comtex […]

To Read More: Dendreon leads drug stocks higher – MarketWatch
categoriaUncategorized commentoComments Off on Dendreon leads drug stocks higher – MarketWatch | dataMay 2nd, 2010
Read All